•Biopharma focused investment banker specializing in strategic transactions and capital advisory services
•Lead execution and oversee analysts' deliverables and analyses, ensuring accuracy and strategic alignment
•Lead and manage discussions with target counter parties to drive deals to close
•Lead strategy engagements across a variety of project types and deliver comprehensive findings and actionable recommendations
•Collaborate with client C-suite and management teams to create impactful marketing materials
•Perform in-depth quantitative financial analyses, including comparable companies, precedent transactions, and discounted cash flow analyses to support deal negotiations
•Rapidly promoted within 6 months in recognition of exceptional project quality improvement and surpassing client expectations, earning the Company Value Award
•Executed commercial assessments and developed revenue forecast models to evaluate the commercial potential of novel products for large pharma clients
•Evaluated product profiles via primary research with KOLs, clinicians, and payers to inform future clinical trial designs, launch scenarios, and R&D investments
•Facilitated workshops with client teams (on-site and virtual) to disseminate research findings and foster constructive discussions amongst key stakeholders to shape strategy and identify growth opportunities
•Received Company Impact award for demonstrating curiosity and resilience, and exceeding client expectations
•Conducted in-depth analysis of competitor data from over ten major medical conferences to inform client strategy
•Generated SWOT analyses and determined competitive threat ratings to pharma companies, marketed drugs, and pipeline assets by analyzing clinical and preclinical data, salesforce readiness, and market access
Univeristy Anon. Bachelor of Science